Clinical Trials Logo

Reading/Writing Disorder clinical trials

View clinical trials related to Reading/Writing Disorder.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT01219309 Completed - ADHD Clinical Trials

Omega-3/Omega-6 Fatty Acids for Attention-Deficit/Hyperactivity Disorder (ADHD): A Trial in Children and Adolescents

Start date: August 2004
Phase: Phase 3
Study type: Interventional

Objective: To assess whether supplementation with Omega 3/6 fatty acids (eye q®) was effective in the treatment of ADHD and its diagnostic subtypes and comorbid conditions, in children and adolescents. Method: Randomized placebo-controlled one-way crossover trial with 75 children and adolescents aged 8-18 years receiving Omega 3/6 or placebo for three months followed by 3 months with Omega 3/6 for all. ADHD symptoms were measured with the investigator-rated ADHD Rating Scale-IV-Parent Version and the Clinical Global Impression (CGI) scale of symptom severity and impairment.